Objective To review the literature describing the efficacy of metformin and topiramate for the
treatment of second-generation antipsychotio–induced weight gain. Data sources Articles …

Background: Changes in weight and metabolic parameters have been commonly reported
in patients with schizophrenia. Metformin has been evaluated in clinical studies to prevent or …

BACKGROUND: Clozapine is the most effective agent in treatment-resistant schizophrenia.
However, it is frequently associated with excessive body weight (BW) gain, type 2 diabetes …

Background Brain derived neurotrophic factor (BDNF) is one of the most essential
neurotrophic factors in the brain. BDNF is involved in learning, memory and locomotion …

Background: One of the major causes of death in schizophrenia is a metabolic syndrome.
The clozapine has the highest rate of weight gain among antipsychotics. It has been shown …

What is known and Objective: Weight‐gain is commonly reported in patients taking atypical
antipsychotic agents. A systematic review was performed to evaluate the effectiveness of …

Objective. The aim of this study was to establish reference values for body composition as
measured by Bioelectrical Impedance Analyser (BIA) in adult females without any …

Introducción: La mayoría de las personas con esquizofrenia presentan disturbios
metabólicos. Objetivo: Revisar y describir los avances científicos relacionados con el …

Methode Voor dit onderzoek is een brede zoekstrategie gehanteerd om publicaties te
vinden die iets zeggen over de effecten van lifestyle interventies bij patiënten met een …

Introduction: The most people with schizophrenia have metabolic disturbances. Objective:
To make a general review and description of the scientific information published lately …